178 related articles for article (PubMed ID: 11988597)
1. Platelet P-selectin levels in relation to plasma soluble P-selectin and beta-thromboglobulin levels in atrial fibrillation.
Kamath S; Blann AD; Caine GJ; Gurney D; Chin BS; Lip GY
Stroke; 2002 May; 33(5):1237-42. PubMed ID: 11988597
[TBL] [Abstract][Full Text] [Related]
2. Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm.
Choudhury A; Chung I; Blann AD; Lip GY
J Am Coll Cardiol; 2007 May; 49(19):1957-64. PubMed ID: 17498581
[TBL] [Abstract][Full Text] [Related]
3. Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy.
Choudhury A; Chung I; Blann AD; Lip GYH
Chest; 2007 Mar; 131(3):809-815. PubMed ID: 17356097
[TBL] [Abstract][Full Text] [Related]
4. A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy.
Kamath S; Blann AD; Chin BS; Lanza F; Aleil B; Cazenave JP; Lip GY
Eur Heart J; 2002 Nov; 23(22):1788-95. PubMed ID: 12419299
[TBL] [Abstract][Full Text] [Related]
5. A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation.
Kamath S; Blann AD; Chin BS; Lip GY
J Am Coll Cardiol; 2002 Aug; 40(3):484-90. PubMed ID: 12142115
[TBL] [Abstract][Full Text] [Related]
6. Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin.
Lip GY; Lip PL; Zarifis J; Watson RD; Bareford D; Lowe GD; Beevers DG
Circulation; 1996 Aug; 94(3):425-31. PubMed ID: 8759084
[TBL] [Abstract][Full Text] [Related]
7. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Nadar SK; Blann AD; Kamath S; Beevers DG; Lip GY
J Am Coll Cardiol; 2004 Jul; 44(2):415-22. PubMed ID: 15261941
[TBL] [Abstract][Full Text] [Related]
8. Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention.
Choudhury A; Chung I; Panja N; Patel J; Lip GYH
Chest; 2008 Sep; 134(3):574-581. PubMed ID: 18641098
[TBL] [Abstract][Full Text] [Related]
9. A study of platelet activation in paroxysmal, persistent and permanent atrial fibrillation.
Kamath S; Chin BS; Blann AD; Lip GY
Blood Coagul Fibrinolysis; 2002 Oct; 13(7):627-36. PubMed ID: 12439149
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation.
Conway DS; Pearce LA; Chin BS; Hart RG; Lip GY
Circulation; 2003 Jul; 107(25):3141-5. PubMed ID: 12796127
[TBL] [Abstract][Full Text] [Related]
11. Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation.
Li-Saw-Hee FL; Blann AD; Lip GY
Stroke; 2000 Apr; 31(4):828-33. PubMed ID: 10753983
[TBL] [Abstract][Full Text] [Related]
12. Effect of acute exercise on the raised plasma fibrinogen, soluble P-selectin and von Willebrand factor levels in chronic atrial fibrillation.
Li-Saw-Hee FL; Blann AD; Edmunds E; Gibbs CR; Lip GY
Clin Cardiol; 2001 May; 24(5):409-14. PubMed ID: 11346250
[TBL] [Abstract][Full Text] [Related]
13. Soluble P-selectin is released from activated platelets in vivo during hemodialysis.
Kawabata K; Nagake Y; Shikata K; Fukuda S; Nakazono H; Takahashi M; Ichikawa H; Makino H
Nephron; 1998; 78(2):148-55. PubMed ID: 9496730
[TBL] [Abstract][Full Text] [Related]
14. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.
Li-Saw-Hee FL; Blann AD; Gurney D; Lip GY
Eur Heart J; 2001 Sep; 22(18):1741-7. PubMed ID: 11511124
[TBL] [Abstract][Full Text] [Related]
15. A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation.
Li-Saw-Hee FL; Blann AD; Lip GY
J Am Coll Cardiol; 2000 Jun; 35(7):1926-31. PubMed ID: 10841245
[TBL] [Abstract][Full Text] [Related]
16. Platelet activation markers in patients with nephrotic syndrome. A comparative study of different platelet function tests.
Sirolli V; Ballone E; Garofalo D; Merciaro G; Settefrati N; Di Mascio R; Di Gregorio P; Bonomini M
Nephron; 2002 Jul; 91(3):424-30. PubMed ID: 12119472
[TBL] [Abstract][Full Text] [Related]
17. Indexes of hypercoagulability measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation secondary to mitral stenosis.
Li-Saw-Hee FL; Blann AD; Goldsmith I; Lip GY
Am J Cardiol; 1999 Apr; 83(8):1206-9. PubMed ID: 10215285
[TBL] [Abstract][Full Text] [Related]
18. Relation of interleukin-6, C-reactive protein, and the prothrombotic state to transesophageal echocardiographic findings in atrial fibrillation.
Conway DS; Buggins P; Hughes E; Lip GY
Am J Cardiol; 2004 Jun; 93(11):1368-73, A6. PubMed ID: 15165916
[TBL] [Abstract][Full Text] [Related]
19. Association of hemostatic markers with atrial fibrillation: a meta-analysis and meta-regression.
Wu N; Tong S; Xiang Y; Wu L; Xu B; Zhang Y; Ma X; Li Y; Song Z; Zhong L
PLoS One; 2015; 10(4):e0124716. PubMed ID: 25884835
[TBL] [Abstract][Full Text] [Related]
20. Comparison of diverse platelet activation markers as indicators for left atrial thrombus in atrial fibrillation.
Tarnowski D; Poitz DM; Plichta L; Heidrich FM; Wiedemann S; Ruf T; Mierke J; Löhn T; Jellinghaus S; Strasser RH; Ibrahim K; Pfluecke C
Platelets; 2018 Jan; 29(1):41-47. PubMed ID: 28287031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
